(IN BRIEF) Merck has officially opened its first fully climate-neutral manufacturing facility in Cork, Ireland, with a €150 million investment that will create more than 200 jobs by 2028. The 3,000-square-meter site will produce advanced filtration devices essential for the … Read the full press release
Posted in Business, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged aseptic processing, Blarney Business Park, Carrigtwohill, cell therapies, climate-neutral manufacturing, CO2 reduction, Cork, filtration devices, gene therapies, Ireland, Jean-Charles Wirth, Life Science, Merck, Merck invests €150 million in Cork to launch first climate-neutral filter production site and create 200 jobs, Merck strengthens European supply resilience with new climate-neutral manufacturing hub in Cork, monoclonal antibodies, partnership, renewable electricity, SHAPE 2040 strategy, sustainability, tangential-flow filtration, vaccines, virus filtration, €150 million investment, €2 billion global expansion, €440 million Ireland investment
(IN BRIEF) Merck and mantro GmbH have established EdiMembre, Inc., a Massachusetts-based Deep Tech spin-out dedicated to advancing the alternative protein sector through Merck’s edible membrane technology. Designed to enable scalable production of structured cultivated meat and plant-based products, the … Read the full press release
Posted in Business, Financial, Germany, Government, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged alternative proteins, cultivated meat, cultured meat scaffolds, Deep Tech spin-out, edible membrane technology, EdiMembre, food security, Laura Matz, Manfred Tropper, mantro GmbH, Massachusetts, Merck, partnership, plant-based protein, protein innovation, Ryan Sylvia, structured meat production, sustainability, Timothy Ryan Olsen, venture building
(IN BRIEF) Merck brought together top executives from Merck, Siemens, Intel, TRUMPF, and ZEISS in Darmstadt to highlight Europe’s critical contributions to the global semiconductor industry. With leading-edge capabilities in materials, lasers, optics, electronics, chip‑design software, and automation, these companies … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Industrial, Investment, Management, Marketing, News, Technology
Tagged AI Chips, Berthold Schmidt, Cedrik Neike, chip‑design software, Europe, Germany, Intel, Kai Beckmann, lasers, materials science, Merck, optics, policy recommendations, R&D, Semiconductor industry, Siemens, smart manufacturing, Sonja Pierer, Thomas Stammler, TRUMPF, value chain collaboration, ZEISS
(IN BRIEF) Merck has awarded its 2025 North American Advance Biotech Grant to Neoclease, a Boston-based startup developing AI-designed gene-editing therapies for Parkinson’s disease and other monogenic disorders. Neoclease will benefit from Merck’s technologies, contract testing, regulatory guidance, and hands-on … Read the full press release
Posted in Artificial Intelligence (AI), Awards, Business, Financial, Germany, Healthcare, Management, Pharma & Biotech, Science, Technology
Tagged 2025 North American winner, Advance Biotech Grant, AI in biotech, Boston biotech, early-stage biotech support, Emprove program, gene-editing therapies, life sciences innovation, M Lab Collaboration Center, Merck, monogenic diseases, NCX-L2, Neoclease, Parkinson's disease, Sebastian Arana, synthetic biology
(IN BRIEF) Merck has entered into a definitive agreement to acquire SpringWorks Therapeutics for approximately $3.9 billion. This acquisition will significantly enhance Merck’s rare tumor portfolio, adding first-in-class therapies for desmoid tumors and NF1-PN. The deal aligns with Merck’s strategy … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged acquisition, biopharmaceuticals, cancer treatments, desmoid tumors, Healthcare Innovation, M&A, Merck, NF1-PN, partnership, pharmaceutical acquisition, rare tumors, SpringWorks Therapeutics, U.S. healthcare
(IN BRIEF) Merck has partnered with NTU Singapore’s Digital Trust Centre (DTC) to advance digital trust technologies in industries requiring high security and compliance. The collaboration will deploy Merck’s digital-physical trust platform in Singapore, the first of its kind in … Read the full press release
(IN BRIEF) Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions from six countries. The program focuses on using Artificial Intelligence (AI) to make semiconductor manufacturing more sustainable, with research projects dedicated to … Read the full press release
Posted in Artificial Intelligence (AI), Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Science, Technology
Tagged AI-Driven, Dr. Anja Jatsch, Germany, Greece, Intel, Merck, partnership, Sanjay Natarajan, Semiconductor Manufacturing, sustainability, Sweden, Switzerland, the Netherlands, United Kingdom, USA
(IN BRIEF) Merck has officially opened a new €290 million biosafety testing facility in Rockville, Maryland, designed to meet the increasing global demand for biosafety testing services. This state-of-the-art facility consolidates various operations, including biosafety testing, analytical development, and cell … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Accelerate Testing Timelines, Benjamin Hein, Biosafety Testing Facility, Drug Safety, Merck, partnership, Rockville, sustainability, USA
(IN BRIEF) Merck and Siemens have signed a strategic partnership to accelerate digital transformation in manufacturing through smart, modular production systems. Siemens will become Merck’s preferred global supplier, providing advanced hardware and software solutions via the Siemens Xcelerator platform. The … Read the full press release
Posted in Business, Germany, Industrial, Infrastructure & Utilities, Technology
Tagged automation, Cedrik Neike, chemical production, digital transformation, electronics, flexibility, global supplier, GMP, Healthcare, INNOVATION, Kai Beckmann, life sciences, Manufacturing, Merck, modular production, Module Type Package, MTP, partnership, Pharmaceutical Production, Siemens, Siemens Xcelerator platform, smart manufacturing, sustainability
(IN BRIEF) Merck has signed an MoU with Gene Therapy Research Institution Co., Ltd. (GTRI) to support the production of gene therapy for Parkinson’s Disease using Merck’s Sf-RVN® Insect Cell Line platform. This collaboration aims to enhance the manufacturing process … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Gene Therapy Production, Gene Therapy Research Institution Co. Ltd. (GTRI), Isao Hatano, Japan, Merck, Parkinson's disease, partnership, sustainability
(IN BRIEF) Merck has joined the “Semiconductor-X” research project, a consortium led by Intel Germany and the Fraunhofer IFF, focusing on the digitalization of semiconductor supply chains to improve resilience and sustainability. The project, funded by the German Federal Ministry … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Technology
Tagged Intel, Kai Beckmann, Merck, partnership, resilience, Semiconductor Supply Chain, sustainability, USA
(IN BRIEF) Merck and The Michael J. Fox Foundation (MJFF) are collaborating to advance Parkinson’s disease research using Merck’s SMCxPRO® immunoassay technology. This initiative aims to detect biomarkers indicating cell dysfunction in PD patients, enhancing research into new treatment options … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Innovative Biomarker Technology, Jean-Charles Wirth, Merck, Michael J. Fox Foundation, Nicole Polinski, Parkinson's Research, partnership, SMCxPRO® immunoassay technology, sustainability
(IN BRIEF) Merck is investing €62 million in a new quality control facility at its Darmstadt headquarters as part of a larger €1.5 billion investment program. Scheduled for completion by mid-2025, the state-of-the-art facility will consolidate 135 employees into a … Read the full press release
Posted in Business, Environment, Financial, Germany, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Darmstadt, expansion, facility, Life Science, Merck, partnership, Quality Standards, Robert Nass, sustainability
(IN BRIEF) Merck, a leading science and technology company, has inaugurated its expanded Life Science distribution center in Schnelldorf, Germany, following a €180 million investment that nearly doubled its size to 25,000 square meters. The upgraded facility now includes manual … Read the full press release
(IN BRIEF) Merck, a prominent science and technology company, announces a €14 million expansion of its M LabTM Collaboration Center in Shanghai, bolstering its support for the biopharmaceutical industry in China. The expansion includes new facilities such as a biology … Read the full press release
Posted in Business, Construction, Environment, Financial, Germany, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged biopharmaceutical, CHINA, Dr. Roy Wu, M LabTM Center, Merck, partnership, Shanghai, sustainability
(IN BRIEF) E. Merck KG, representing the Merck family’s interests in Merck KGaA, has disclosed the results of its regular board elections. Johannes Baillou, with 30 years of board experience at E. Merck KG, has been elected as Chairman of … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science, Technology
Tagged André Wyss, appointment, Carl Christoph Schweickert, Dr Wolfgang Büchele, Dr. Daniel Thelen, Dr. Frank Stangenberg-Haverkamp, Dr. Katharina Kraft, Dr. Susanne Schaffert, E. Merck KG, Family Board Elections, Johannes Baillou, leadership, Merck, Michael Kleinemeier, Professor Dr. Simon Thelen
(IN BRIEF) Merck, a leading science and technology company, has inaugurated the Merck Digital Hub in Singapore, its first digital hub outside of the US and Europe. Supported by the Singapore Economic Development Board (EDB), the hub aims to accelerate … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Athinia™, Digital Hub, Healthcare, Laura Matz, Merck, partnership, Semiconductor Innovation, Singapore, Singapore Economic Development Board (EDB), sustainability, Syntropy™, Wan Yee Goh
(IN BRIEF) Merck has completed the second phase of its new €29 million Biologics Testing Center in China, adding 1,500 square meters to the facility. This expansion includes the first biosafety laboratories for Merck in the Chinese market, enabling clients … Read the full press release
(IN BRIEF) Merck, a prominent science and technology company, has entered into a strategic partnership with Jiangsu Hengrui Pharmaceuticals. This collaboration includes an exclusive global license (excluding China) to develop and commercialize Hengrui’s advanced PARP1 inhibitor, HRS-1167. Additionally, there is … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged ADC, antibody-drug conjugate, ATM, ATR, Cancer, CEACAM5-targeting ADC, Claudin-18.2, Danny Bar-Zohar, DDR cascade, DNA-PK, Frank Jiang, Hengrui, HRS-1167, inhibitor, Jiangsu Hengrui Pharmaceuticals Co. Ltd., M9140, Merck, metastatic colorectal cancer, oncology, PARP, PARP1, poly (ADP-ribose) polymerase 1, SHR-A1904
(IN BRIEF) Merck, a leading science and technology company, has announced its expectation to return to organic sales growth in fiscal 2024. This was revealed during the company’s Capital Markets Day. Despite challenging market conditions in its Life Science and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Management, Pharma & Biotech, Technology
Tagged artificial-intelligence, BAVENCIO™, Belén Garijo, Capital Markets Day, electronics, evobrutini, Healthcare, Internet of Things, IoT, Life Science, MAVENCLAD, Merck, semiconductor materials, Xevinapant
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?